Carmen Ruggiero
Valbonne, 06560, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Steroidogenic factor-1 regulates a core set of target genes to promote malignancy in adrenocortical carcinoma.
Journal: European journal of endocrinology
Published: January 10, 2025
ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures.
Journal: European journal of endocrinology
Published: April 23, 2023
Steroidogenic Factor 1, a Goldilocks Transcription Factor from Adrenocortical Organogenesis to Malignancy.
Journal: International journal of molecular sciences
Published: January 10, 2023
Complex and pleiotropic signaling pathways regulated by the secreted protein augurin.
Journal: Cell communication and signaling : CCS
Published: December 23, 2022
FSCN1 as a new druggable target in adrenocortical carcinoma.
Journal: International journal of cancer
Published: November 21, 2022
How good are the current models of adrenocortical carcinoma for novel drug discovery?
Journal: Expert opinion on drug discovery
Published: October 20, 2021
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function.
Journal: Clinical and translational medicine
Published: July 29, 2021
Targeting the cytoskeleton against metastatic dissemination.
Journal: Cancer metastasis reviews
Published: September 19, 2020
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 10, 2018
The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways.
Journal: Molecular and cellular endocrinology
Published: November 27, 2017
Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo.
Journal: International journal of cancer
Published: October 19, 2017
VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma.
Journal: Oncotarget
Published: September 06, 2017
Last Updated: 09/26/2026